Oliai C, Park S, Damon LE, Jonas BA, et al. CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial. Leuk Lymphoma 2024 Dec 17:1-7. doi: 10.1080/10428194.2024.2438809.
PMID: 39689718